| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.2932 | 14 |
| GSM780708 | Untreated after 4 days (C2_1) | 41.8692 | 13 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.5385 | 20 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.3887 | 29 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.3115 | 34 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.785 | 48 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.7709 | 16 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.3647 | 43 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.9249 | 32 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 42.9027 | 17 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.6371 | 30 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.2185 | 33 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.2397 | 14 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.7317 | 35 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.2992 | 29 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.557 | 39 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.2523 | 42 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.3517 | 34 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.5504 | 47 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 48.2341 | 42 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.4868 | 20 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.3299 | 24 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 41.1885 | 10 |